Revolution Healthcare Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REVH research report →
Price Chart
About the company
Revolution Healthcare Acquisition Corp. currently lacks significant operational activities. Its core mission involves acquiring other companies and assets through a range of business combinations, such as mergers, share exchanges, stock purchases, or reorganizations.
- CEO
- Jay S. Markowitz
- IPO
- 2021
- HQ
- Cambridge, MA, US
Get TickerSpark's AI analysis on REVH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $0
- P/E
- 12.56
- PEG
- 0.22
- P/S
- 0.00
- P/B
- -17.83
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -142.76%
- ROIC
- -0.42%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-2,332,000
- Net Income
- $46.44M+0.0%
- EPS
- $0.80+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $10.50
- 52W Low
- $9.62
- 50D MA
- $10.00
- 200D MA
- $9.85
- Beta
- 0.00
- RSI (14)
- 58
- Avg Volume
- 388.73K
No earnings-call transcripts are available for REVH yet.
of shares held by institutions
68 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 699.78K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 21 | Fielding Paul | other | 0 |
| May 1, 21 | REV Sponsor LLC | sell | 125,000 |
| Mar 17, 21 | REV Sponsor LLC | other | 0 |
| Apr 27, 21 | REV Sponsor LLC | sell | 1,875 |
| Mar 17, 21 | Doren Jason | other | 0 |
| Mar 17, 21 | Engskov Kris | other | 0 |
| Mar 17, 21 | FRIEDMAN CATHY | other | 0 |
| Mar 17, 21 | LEIDEN JEFFREY M | other | 0 |
| Mar 17, 21 | Markowitz Jay | other | 0 |
| Mar 17, 21 | MCDONNELL MARK | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our REVH coverage
Recent articles, reports, and earnings notes.
No research on REVH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate REVH report →